These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28806036)

  • 1. FDA Issues New Fluoroquinolone Safety Warnings and Prescribing Restrictions.
    Peters S
    S D Med; 2016 Sep; 69(9):418-421. PubMed ID: 28806036
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
    Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
    JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
    Cowart K; Worley M; Rouby NE; Sando K
    Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA warning and study highlight fluoroquinolone risks.
    Kuehn BM
    JAMA; 2013 Sep; 310(10):1014. PubMed ID: 24026585
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA boxed warnings: how to prescribe drugs safely.
    O'Connor NR
    Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA adds "black box" warning label to fluoroquinolone antibiotics.
    Tanne JH
    BMJ; 2008 Jul; 337(7662):a816. PubMed ID: 18632714
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions.
    Alford JC; Saseen JJ; Allen RR; Nair KV
    Pharmacotherapy; 2012 Jul; 32(7):623-30. PubMed ID: 22570173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals.
    Yarrington ME; Anderson DJ; Dodds Ashley E; Jones T; Davis A; Johnson M; Lokhnygina Y; Sexton DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1297-1300. PubMed ID: 31474240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steps forward and backward within the fluoroquinolone class.
    Hedge DD
    S D J Med; 2000 Apr; 53(4):137-8. PubMed ID: 10790988
    [No Abstract]   [Full Text] [Related]  

  • 10. Outpatient Fluoroquinolone Prescription Fills in the United States, 2014 to 2020: Assessing the Impact of Food and Drug Administration Safety Warnings.
    Buehrle DJ; Wagener MM; Clancy CJ
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0015121. PubMed ID: 33875430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From off-label prescribing towards a new FDA.
    Tabarrok A
    Med Hypotheses; 2009 Jan; 72(1):11-3. PubMed ID: 18835103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Federal Drug Administration Fluoroquinolone Warning and a Practical Approach to Managing Patients.
    Steiger SN; Nailor MD
    Conn Med; 2016 Nov; 80(10):601-605. PubMed ID: 29898335
    [No Abstract]   [Full Text] [Related]  

  • 13. Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits.
    Kabbani S; Hersh AL; Shapiro DJ; Fleming-Dutra KE; Pavia AT; Hicks LA
    Clin Infect Dis; 2018 Jun; 67(1):134-136. PubMed ID: 29373664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.
    Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1996 Sep; 276(10):774. PubMed ID: 8769577
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing changes following fluoroquinolone safety warning.
    Drug Ther Bull; 2024 Jul; 62(7):100. PubMed ID: 38816185
    [No Abstract]   [Full Text] [Related]  

  • 17. Positive outcomes through the appropriate use of off-label prescribing.
    Bright JL
    Arch Intern Med; 2006 Dec 11-25; 166(22):2554-5; author reply 2555. PubMed ID: 17159026
    [No Abstract]   [Full Text] [Related]  

  • 18. Off-label prescribing explained. Why your doctor may recommend meds that aren't FDA-approved for your condition.
    Johns Hopkins Med Lett Health After 50; 2011 Jun; 23(4):7. PubMed ID: 21702115
    [No Abstract]   [Full Text] [Related]  

  • 19. Moxifloxacin: new preparation. A me-too with more cardiac risks.
    Prescrire Int; 2002 Dec; 11(62):168-9. PubMed ID: 12469694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA prohibits extralabel use of two drug classes.
    J Am Vet Med Assoc; 1997 Aug; 211(3):269. PubMed ID: 9262656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.